Acknowledgements
Cancer
CANCER
The authors thank Irina Shchaveleva, Chun Zhou, and Judy Fang from the FCCC Immune Monitoring/Cell Sorting Facility for technical support. Jeffrey Sherman, Jeffrey Nieves, and Amy Grahn for support from Horizon Pharma. The NCI Cancer Center Support Grant (CA06927; FCCC) for support of core facilities utilized (Immune Monitoring/Cell Sorting, High Throughput Screening, and Biostatistics & Bioinformatics Facilities) and philanthropic funds from the FCCC In Vino Vita fundraiser, FCCC Bucks County and Mainline Boards of Associates, C.W.A. Local 13000 Jim Willer Golf Tournament, and the FCCC Dragon Boat Team. Employees of Horizon Therapeutics did not contribute to or influence study design, data collection, or data analysis. Full support for clinical trial provided by Horizon Therapeutics, PLC.